What is new in the first European Society of Cardiology and European Atherosclerosis Society Guidelines for the management of dyslipidaemias?

The first European guidelines for the management of dyslipidaemias produced jointly by the European Society of Cardiology and the European Atherosclerosis Society deal with the management of dyslipidaemias as an integral and important part of cardiovascular diseases (CVD) prevention. According to them, in patients at very high CVD risk (established CVD, type 2 diabetes, type 1 diabetes with target organ damage, moderate to severe chronic kidney disease or a SCORE level ≥10 %) the LDL-cholesterol goal should be <1.8 mmol/L and/or reduced by a least 50% when target level cannot be reached. In patients at high CVD risk (markedly elevated single risk factors eg. hypercholesterolaemia, and SCORE level ≥5 to <10%) a LDL-cholesterol goal <2.5 mmol/L should be considered. In subjects at moderate risk (SCORE level >1 to ≤5%) LDL-cholesterol goal <3.0 mmol/L should be considered and in those at low risk (SCORE level <1%) either no lipid intervention or, if LDLcholesterol is